Gordon Binder
Gordon M. Binder (born 1935) is an American businessman.[1][2][3]
Biography
Early life
Gordon Binder was born in Missouri.[2] He graduated from Purdue University with a Bachelor of Science in Electrical Engineering and received an M.B.A. from the Harvard Business School as a Baker Scholar.[1][2]
Career
He worked in managing position at Litton Industries and the Ford Motor Company.[1][3] He served as Chief Financial Officer at the System Development Corporation.[1][3] In 1982, he joined Amgen as CFO.[1] From 1988 to 2000, he served as its CEO.[1][3][4]
He is as the Founder and Managing Director of Coastview Capital, a private investment firm.[1][3][5] He also serves as Chairman of SRU Biosystems.[6] He sits on the Boards of Directors of Acadia Pharmaceuticals, Cellular Genomics, PhRMA and the Biotechnology Industry Organization.[1][3] along with Henri Termeer.[7]
He is a member of the Board of Trustees of the Massachusetts Institute of Technology, the California Institute of Technology and the American Enterprise Institute.[1][3][8][9] He was elected a Fellow of the American Academy of Arts and Sciences in 2001.[10]
Bibliography
- Science lessons: What the Business of Biotech Taught Me About Management (with Philip Bashe, Harvard Business Review Press, 2008)
References
- 1 2 3 4 5 6 7 8 9 "Gordon M. Binder", Bloomberg Business Week, nd
- 1 2 3 Harvard Business School
- 1 2 3 4 5 6 7 "Biography", Milken Institute, nd
- ↑ Lawrence M. Fisher, BUSINESS PEOPLE; Amgen Officer Shifts Surprise to Analysts, The New York Times, October 27, 1988
- ↑ Bloomerg BusinessWeek: Coastview Capital
- ↑ A Sharper Nose for Danger, Bloomberg BusinessWeek, May 24, 2004
- ↑ Terrapinn Holdings Ltd (2015). Mr Henri Termeer: Chief Executive Officer, Former Genzyme. Orphan Drug Congress. Retrieved 27 September 2015.
- ↑ The MIT Corporation
- ↑ American Enterprise Institute Board of Trustees
- ↑ "Book of Members, 1780–2010: Chapter B" (PDF). American Academy of Arts and Sciences. Retrieved July 20, 2011.